𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: A retrospective study

✍ Scribed by Antoni Castells; Joan Saló; Ramon Planas; Juan Carlos Quer; Angels Ginès; Jaume Boix; Pere Ginès; Miquel Angel Gassull; Josep Terés; Vicente Arroyo; Joan Rodés


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
814 KB
Volume
20
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Despite the efficacy of shunt surgery in the treatment of variceal bleeding, less effective nonoperative therapies are being substituted because surgical shunt does not modify survival and increases hepatic encephalopathy. However, the real impact of shunt surgery on the natural history of ascites and its complications has not been established. The course of 204 Child-Pugh A and B cirrhotic patients with variceal bleeding included in three controlled trials of our units who survived first hospitalization was updated. Ninetyeight patients (group I) were treated by portacaval(56 patients) or distal splenorenal (42 patients) shunt, whereas 106 (group 11) were treated by nonshunt procedures (sclerotherapy in 89 patients and staple transection in 17 patients). As expected, the 5-yr probability of variceal rebleeding was lower (13% vs. 44%) and hepatic encephalopathy higher (50% vs. 28%) in group I than in group 11, and survival was similar (67% vs. 60%). Shunt surgery had a great impact on the natural history of ascites and its complications. The probability of occurrence of ascites (15% vs. 73%; p < O.OOOl), spontaneous bacterial peritonitis (2% vs. 21%; p < 0.0001) and hepatorenal syndrome (4% vs. 21%; p < 0.01) was greatly reduced. These beneficial effects accounted for the lower percentage patients requiring readmissions (51% vs. 70%; p = 0.02) and shorter total time spent in hospital (14 f 22 vs. 26 f 39 daydpatient; p = 0.01) in group 1. These data indicate that shunt surgery, in addition to reducing the probability of rebleeding, markedly decreases the probability of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome development. Therefore, ascites and its complications should be considered in any therapeutic trial assessing the efficacy of surgical or percutaneous portacaval anastomosis on variceal bleeding.


📜 SIMILAR VOLUMES


Transjugular intrahepatic portosystemic
✍ Manuela Merli; Francesco Salerno; Oliviero Riggio; Roberto de Franchis; Franco F 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Transjugular intrahepatic portosystemic shunt (TIPS), a new technique for the treatment of portal hypertension, has been successful in preliminary studies to treat acute variceal hemorrhage and to prevent variceal rebleeding. The purpose of this multicenter, randomized controlled trial is to co

Treatment recommendations for chronic he
✍ Myron John Tong; Carlos Hsien; Leeyen Hsu; Hai-En Sun; Lawrence Mitchell Blatt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

Current guidelines for treatment of chronic hepatitis B include hepatitis B e antigen (HBeAg) status, levels of hepatitis B virus (HBV) DNA, and serum alanine aminotransferase (ALT) values in the setting of either chronic hepatitis or cirrhosis. Based on findings from a prospective study of hepatiti